Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
platelet-rich fibrin + minocycline
- Development stage
- Unknown
- Lead developer
- Center for Advanced Rejuvenation and Esthetics
- Modality
- Small Molecules
- Administration
- Topical
01
Overview
Platelet-rich fibrin (PRF) combined with minocycline is an adjunctive therapeutic intervention used in non-surgical periodontal therapy (NSPT) for the treatment of periodontitis. PRF is an autologous, second-generation platelet concentrate derived from the patient's own blood, forming a fibrin matrix that contains high concentrations of platelets, leucocytes, and essential growth factors such as platelet-derived growth factor (PDGF), transforming growth factor beta (TGF-β), and vascular endothelial growth factor (VEGF). These components facilitate tissue healing and regeneration. Minocycline is a broad-spectrum tetracycline antibiotic that provides antimicrobial activity against periodontal pathogens. In this combination, the PRF matrix serves as a biologic scaffold and a local delivery system for the antibiotic, aiming to resolve inflammation and reduce periodontal pocket depth more effectively than standard scaling and root planing alone. This specific combination is being evaluated by the Center for Advanced Rejuvenation and Esthetics in randomized clinical trials.
- Other names
- Platelet-rich Fibrin With MinocyclinePRF with Minocycline
02
Targets
Bacterial RibosomePDGFR (PDGFR family)TGFBR (TGF-beta receptor)VEGFR (VEGFR family)
Beyond the preview
Go deeper on platelet-rich fibrin + minocycline.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on platelet-rich fibrin + minocycline.